glycine has been researched along with Acute Disease in 109 studies
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare 3-month stroke outcomes and stroke-related health care resource use between the US and Canada in the Glycine Antagonist in Neuroprotection (GAIN) Americas study." | 9.11 | Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial. ( Hux, M; Johnston, KC; Nielsen, K; Phillips, S; Rundek, T; Watson, D, 2004) |
| "Oral administration of ESL (100 mg/kg), previous to latrunculin A microperfusion, completely prevented acute latrunculin A-induced seizures as well as chronic seizures and all EEG chronic signs of paroxysmal activity." | 7.80 | Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014) |
| "The authors evaluated the protective effect of sivelestat sodium on postoperative lung dysfunction in patients with type A acute aortic dissection who underwent aortic arch surgery with cardiopulmonary bypass (CPB) under deep hypothermia with circulatory arrest (DHCA)." | 7.74 | Protective effect of sivelestat sodium (Eraspol) on postoperative lung dysfunction in patients with type A acute aortic dissection: a pilot study. ( Dardik, A; Kainuma, M; Kondo, Y; Muto, A; Nishibe, T; Ohara, Y; Takeda, K, 2008) |
| "The present study investigated whether chemokines are involved in hydrogen sulfide (H2S)-associated pathogenesis of acute pancreatitis and associated lung injury." | 7.74 | Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury. ( Bhatia, M; Moore, PK; Tamizhselvi, R, 2008) |
| "Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine." | 7.74 | Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment. ( Kodama, D; Ono, H; Takasu, K; Tanabe, M; Yamaguchi, S, 2008) |
| "Morphine-augmented cholescintigraphy optimizes the diagnosis of acute cholecystitis in patients with the suggestive, but not pathognomonic, cholescintigraphic pattern at 1 hr of gallbladder nonvisualization with a pericholecystic rim sign, regardless of its intensity." | 7.69 | Gallbladder nonvisualization with pericholecystic rim sign: morphine-augmentation optimizes diagnosis of acute cholecystitis. ( Achong, DM; Chin, CT; Oates, E; Selland, DL, 1996) |
| "The utility of morphine-augmented cholescintigraphy was reviewed in 32 patients with suspected acute cholecystitis." | 7.68 | Morphine-augmented cholescintigraphy in acute cholecystitis. A satisfactory alternative to delayed imaging. ( Bitterman, P; Gooch, D; Kistler, AM; Ziessman, HA, 1991) |
| "Acute hypotension was induced by intravenous infusion of sodium nitroprusside (SNP)." | 5.36 | [Changes of gamma-aminobutyric acid and glycine released in the medial vestibular nucleus following acute hypotension in conscious rats]. ( An, Y; Jin, QH; Jin, YZ; Li, XL, 2010) |
| "Acute pancreatitis was induced in mice by 10 hourly intraperitoneal injections of caerulein (50 (g/kg)." | 5.35 | Pro-inflammatory effects of hydrogen sulphide on substance P in caerulein-induced acute pancreatitis. ( Bhatia, M; Moochhala, SM; Ng, SW; Sidhapuriwala, JN; Tamizhselvi, R, 2008) |
| "Hydrogen sulfide (H2S) is a naturally occurring gas with potent vasodilator activity." | 5.33 | Role of hydrogen sulfide in acute pancreatitis and associated lung injury. ( Bhatia, M; Fu, D; Lau, HY; Moochhala, SM; Moore, PK; Wong, FL, 2005) |
| "Acute cholecystitis was deemed present if there was nonvisualization of the gallbladder 30 min post-morphine administration; no cystic duct obstruction was present if the gallbladder was demonstrated pre- or post-morphine administration." | 5.28 | Morphine-augmented cholescintigraphy: its efficacy in detecting acute cholecystitis. ( Balon, H; Fink-Bennett, D; Robbins, T; Tsai, D, 1991) |
| "We analyzed data from the Glycine Antagonist in Neuroprotection (GAIN) Americas trial, in which 1604 non-obtunded patients with acute stroke were treated within 6 hours of symptom onset irrespective of hemorrhagic (N = 237) versus ischemic (N = 1367) subtype." | 5.14 | Comparison of outcomes after intracerebral hemorrhage and ischemic stroke. ( Chiu, D; Elkind, MSV; Gerber, LM; Peterson, L; Rosand, J; Silverstein, MD, 2010) |
| "To compare 3-month stroke outcomes and stroke-related health care resource use between the US and Canada in the Glycine Antagonist in Neuroprotection (GAIN) Americas study." | 5.11 | Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial. ( Hux, M; Johnston, KC; Nielsen, K; Phillips, S; Rundek, T; Watson, D, 2004) |
| "Oral administration of ESL (100 mg/kg), previous to latrunculin A microperfusion, completely prevented acute latrunculin A-induced seizures as well as chronic seizures and all EEG chronic signs of paroxysmal activity." | 3.80 | Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014) |
| "Isovaline reduced responses in mouse pain models without producing acute toxicity, possibly by enhancing receptor modulation of nociceptive information." | 3.76 | Analgesic properties of the novel amino acid, isovaline. ( Chung, CC; MacLeod, BA; Puil, E; Ries, CR; Schwarz, SK; Wang, JT, 2010) |
| "The authors evaluated the protective effect of sivelestat sodium on postoperative lung dysfunction in patients with type A acute aortic dissection who underwent aortic arch surgery with cardiopulmonary bypass (CPB) under deep hypothermia with circulatory arrest (DHCA)." | 3.74 | Protective effect of sivelestat sodium (Eraspol) on postoperative lung dysfunction in patients with type A acute aortic dissection: a pilot study. ( Dardik, A; Kainuma, M; Kondo, Y; Muto, A; Nishibe, T; Ohara, Y; Takeda, K, 2008) |
| "The present study investigated whether chemokines are involved in hydrogen sulfide (H2S)-associated pathogenesis of acute pancreatitis and associated lung injury." | 3.74 | Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury. ( Bhatia, M; Moore, PK; Tamizhselvi, R, 2008) |
| "Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine." | 3.74 | Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment. ( Kodama, D; Ono, H; Takasu, K; Tanabe, M; Yamaguchi, S, 2008) |
| "The aim of the present study was to examine whether neutrophil and its elastase activity played consequential roles in the progression of gut barrier dysfunction during acute alveolar hypoxia by using a specific neutrophil elastase inhibitor, sivelestat." | 3.74 | Inhibition of neutrophil elastase attenuates gut mucosal injury evoked by acute alveolar hypoxia in rabbits. ( Funakoshi, Y; Ishizaka, A; Katori, N; Kawabata, K; Kotake, Y; Morisaki, H; Nakamura, N; Suzuki, T; Takeda, J; Yajima, S; Yamada, S, 2007) |
| "Morphine intervention in cholescintigraphy decreases imaging time to diagnose acute cholecystitis." | 3.69 | Morphine-augmented cholescintigraphy enhances duodenogastric reflux. ( Lee, JK; Magoun, S; Ryo, UY; Shih, WJ; Wierzbinski, B, 1995) |
| "Morphine-augmented cholescintigraphy optimizes the diagnosis of acute cholecystitis in patients with the suggestive, but not pathognomonic, cholescintigraphic pattern at 1 hr of gallbladder nonvisualization with a pericholecystic rim sign, regardless of its intensity." | 3.69 | Gallbladder nonvisualization with pericholecystic rim sign: morphine-augmentation optimizes diagnosis of acute cholecystitis. ( Achong, DM; Chin, CT; Oates, E; Selland, DL, 1996) |
| "The utility of morphine-augmented cholescintigraphy was reviewed in 32 patients with suspected acute cholecystitis." | 3.68 | Morphine-augmented cholescintigraphy in acute cholecystitis. A satisfactory alternative to delayed imaging. ( Bitterman, P; Gooch, D; Kistler, AM; Ziessman, HA, 1991) |
| " In order to elucidate the significance of GAA synthesis in the pancreas, the author measured serum concentration of GAA, creatine, and the renal and pancreatic GAT activity in control, streptozotocin (STZ)-induced diabetic, insulin-treated diabetic, and ethionine-induced acute pancreatitis rats." | 3.67 | [Study of impaired metabolism of guanidinoacetic acid in uremia--the compensatory role of the pancreas in guanidinoacetic acid synthesis]. ( Hirata, M, 1989) |
| "When faced with a patient with possible acute cholecystitis, technetium-99m-HIDA scintigraphy should be the primary diagnostic procedure performed." | 3.66 | Diagnostic utility of cholescintigraphy and ultrasonography in acute cholecystitis. ( Burrell, MI; Cahow, CE; Caride, V; Zeman, RK, 1981) |
| " All patients were asked to keep a daily diary to evaluate gastric tolerability, whereas overall tolerability was evaluated by recording adverse effects and determining the common laboratory parameters." | 2.70 | [Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis]. ( Biasi, G; Marcolongo, R, 2001) |
| " The dosage used in Group A1 was as efficacious as that used in Group A2." | 2.68 | [Clinical trial comparing a new NSAID with 2 different dosages and diclofenac in patients with arthralgia in acute phase]. ( Alicicco, E; Delfino, M; Kleszczynski, D, 1995) |
| " The highest dosage employed (1800 mg/die) performs an excellent therapeutical activity which is equivalent to that at the 1200 mg in reducing pain symptomatology, but on the average less tolerated." | 2.67 | [A clinical study to determine the optimal dosage of ST-679 in the treatment of rheumatic diseases]. ( Donati, G; Spinazzè, R, 1993) |
| "Treatment with GSK4112 also downregulated the activities of caspase-3 and caspase-8, suppressed hepatocyte apoptosis." | 1.62 | REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice. ( Fan, K; Jiang, R; Li, L; Liu, G; Shao, R; Shen, Y; Tang, L; Wu, X; Yang, Y; Zhang, L, 2021) |
| " Further, when the human condition was simulated in animals, there was deprivation in body weight and glucose levels in starved litchi seed dosed rats, causing hypoglycemia." | 1.51 | Methylenecyclopropyl glycine, not pesticide exposure as the primary etiological factor underlying hypoglycemic encephalopathy in Muzaffarpur, India. ( Asthana, S; Das, M; Dixit, S; Kumar, A; Singh, SP; Srivastava, A; Tripathi, A, 2019) |
| "Sivelestat treatment significantly reduced the protein level, neutrophil count, neutrophil elastase activity in BALF, and severity of histopathologic findings on day 14 for mice administered with 250 mg/kg of gefitinib." | 1.46 | Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in mice. ( Arimura-Omori, M; Hamada, N; Harada, E; Ikeda-Harada, C; Mikumo, H; Nakanishi, Y; Ogata-Suetsugu, S; Suzuki, K; Yanagihara, T; Yokoyama, T, 2017) |
| "Surgery for type A acute aortic dissection (AAD) is associated with a high mortality and incidence of postoperative complications, including acute respiratory failure and coagulopathy." | 1.36 | Efficacy of neutrophil elastase inhibitor on type A acute aortic dissection. ( Fujita, K; Hata, M; Minami, K; Niino, T; Osaka, S; Sezai, A; Shimura, K; Unosawa, S; Yoshitake, I, 2010) |
| "Acute hypotension was induced by intravenous infusion of sodium nitroprusside (SNP)." | 1.36 | [Changes of gamma-aminobutyric acid and glycine released in the medial vestibular nucleus following acute hypotension in conscious rats]. ( An, Y; Jin, QH; Jin, YZ; Li, XL, 2010) |
| "Acute pancreatitis was induced in mice by 10 hourly intraperitoneal injections of caerulein (50 (g/kg)." | 1.35 | Pro-inflammatory effects of hydrogen sulphide on substance P in caerulein-induced acute pancreatitis. ( Bhatia, M; Moochhala, SM; Ng, SW; Sidhapuriwala, JN; Tamizhselvi, R, 2008) |
| "Respiratory failure was relieved within 5 days following treatment." | 1.35 | [Acute respiratory failure due to pneumocystis pneumonia successfully treated with combined use of sivelestat sodium hydrate]. ( Chida, K; Fujisawa, T; Harada, M; Imokawa, S; Mori, K; Sagisaka, S; Sano, T; Suda, T; Uchiyama, H; Ukita, T; Yasuda, K, 2008) |
| "Sivelestat is a specific neutrophil elastase inhibitor, and this study aims to evaluate the effects of sivelestat on postoperative respiratory failure due to AAD." | 1.33 | The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection. ( Amano, J; Fukui, D; Furusawa, T; Sakaguchi, M; Seto, T; Terasaki, T; Tsukioka, K; Wada, Y, 2006) |
| "Pretreatment of sivelestat demonstrated a protective effect on both intravascular and extravascular damage in the lung, whereas posttreatment only suppressed the latter damage." | 1.33 | Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. ( Fukunaga, M; Iba, T; Kidokoro, A; Sugimotoa, K; Takuhiro, K; Yoshikawa, S, 2006) |
| "Respiratory failure was relieved within 2 weeks following treatment There was no four-fold rise in screen viral titers and screening investigations of autoantibodies were negative." | 1.33 | [Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy]. ( Chida, K; Enomoto, N; Imokawa, S; Nagayama, M; Sano, T; Suda, T; Todate, A; Uchiyama, H; Yasuda, K, 2006) |
| "Hydrogen sulfide (H2S) is a naturally occurring gas with potent vasodilator activity." | 1.33 | Role of hydrogen sulfide in acute pancreatitis and associated lung injury. ( Bhatia, M; Fu, D; Lau, HY; Moochhala, SM; Moore, PK; Wong, FL, 2005) |
| "Mortality associated with endotoxin shock is likely mediated by Kupffer cells, alveolar macrophages, and circulating neutrophils." | 1.31 | Dietary glycine blunts lung inflammatory cell influx following acute endotoxin. ( Enomoto, N; Madren, J; Rose, ML; Seabra, V; Thurman, RG; Wheeler, MD; Yamashima, S, 2000) |
| "The authors present a case of type II choledochal cyst shown on a hepatobiliary scan in a patient with possible acute cholecystitis." | 1.31 | Hepatobiliary scan showing type II choledochal cyst. ( Falen, S; McCartney, W; Wienke, J, 2001) |
| "Acute pancreatitis is a dreaded complication of biliary calculus disease, and several radiographic signs have been reported in association with this condition." | 1.28 | The scintigraphic "duodenal cut off sign" in acute pancreatitis. ( Alexander, HG; Buckner, AB; Shanley, DJ, 1991) |
| "Acute cholecystitis was deemed present if there was nonvisualization of the gallbladder 30 min post-morphine administration; no cystic duct obstruction was present if the gallbladder was demonstrated pre- or post-morphine administration." | 1.28 | Morphine-augmented cholescintigraphy: its efficacy in detecting acute cholecystitis. ( Balon, H; Fink-Bennett, D; Robbins, T; Tsai, D, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (24.77) | 18.7374 |
| 1990's | 26 (23.85) | 18.2507 |
| 2000's | 34 (31.19) | 29.6817 |
| 2010's | 19 (17.43) | 24.3611 |
| 2020's | 3 (2.75) | 2.80 |
| Authors | Studies |
|---|---|
| Shao, R | 1 |
| Yang, Y | 1 |
| Fan, K | 1 |
| Wu, X | 1 |
| Jiang, R | 1 |
| Tang, L | 1 |
| Li, L | 1 |
| Shen, Y | 1 |
| Liu, G | 1 |
| Zhang, L | 1 |
| Cerchione, C | 1 |
| Martinelli, G | 1 |
| Stuani, L | 1 |
| Sabatier, M | 1 |
| Saland, E | 1 |
| Cognet, G | 1 |
| Poupin, N | 1 |
| Bosc, C | 1 |
| Castelli, FA | 1 |
| Gales, L | 1 |
| Turtoi, E | 1 |
| Montersino, C | 1 |
| Farge, T | 1 |
| Boet, E | 1 |
| Broin, N | 1 |
| Larrue, C | 1 |
| Baran, N | 1 |
| Cissé, MY | 1 |
| Conti, M | 1 |
| Loric, S | 1 |
| Kaoma, T | 1 |
| Hucteau, A | 1 |
| Zavoriti, A | 1 |
| Sahal, A | 1 |
| Mouchel, PL | 1 |
| Gotanègre, M | 1 |
| Cassan, C | 1 |
| Fernando, L | 1 |
| Wang, F | 1 |
| Hosseini, M | 1 |
| Chu-Van, E | 1 |
| Le Cam, L | 1 |
| Carroll, M | 1 |
| Selak, MA | 1 |
| Vey, N | 1 |
| Castellano, R | 1 |
| Fenaille, F | 1 |
| Turtoi, A | 1 |
| Cazals, G | 1 |
| Bories, P | 1 |
| Gibon, Y | 1 |
| Nicolay, B | 1 |
| Ronseaux, S | 1 |
| Marszalek, JR | 1 |
| Takahashi, K | 1 |
| DiNardo, CD | 1 |
| Konopleva, M | 1 |
| Pancaldi, V | 1 |
| Collette, Y | 1 |
| Bellvert, F | 1 |
| Jourdan, F | 1 |
| Linares, LK | 1 |
| Récher, C | 1 |
| Portais, JC | 1 |
| Sarry, JE | 1 |
| Asthana, S | 1 |
| Dixit, S | 1 |
| Srivastava, A | 1 |
| Kumar, A | 1 |
| Singh, SP | 1 |
| Tripathi, A | 1 |
| Das, M | 1 |
| Santarelli, F | 1 |
| Cassanello, M | 1 |
| Enea, A | 1 |
| Poma, F | 1 |
| D'Onofrio, V | 1 |
| Guala, G | 1 |
| Garrone, G | 1 |
| Puccinelli, P | 1 |
| Caruso, U | 1 |
| Porta, F | 1 |
| Spada, M | 1 |
| Wang, H | 1 |
| Wang, S | 1 |
| Tang, A | 1 |
| Gong, H | 1 |
| Ma, P | 1 |
| Chen, L | 1 |
| Guercio, GD | 1 |
| Bevictori, L | 1 |
| Vargas-Lopes, C | 1 |
| Madeira, C | 1 |
| Oliveira, A | 1 |
| Carvalho, VF | 1 |
| d'Avila, JC | 1 |
| Panizzutti, R | 1 |
| Sierra-Paredes, G | 1 |
| Loureiro, AI | 1 |
| Wright, LC | 1 |
| Sierra-Marcuño, G | 1 |
| Soares-da-Silva, P | 1 |
| Reese, SR | 1 |
| Wilson, NA | 1 |
| Huang, G | 1 |
| Redfield, RR | 1 |
| Zhong, W | 1 |
| Djamali, A | 1 |
| De Raadt, WM | 1 |
| Wijnen, PA | 1 |
| Bast, A | 1 |
| Bekers, O | 1 |
| Drent, M | 1 |
| Ham, DJ | 1 |
| Caldow, MK | 1 |
| Chhen, V | 1 |
| Chee, A | 1 |
| Wang, X | 1 |
| Proud, CG | 1 |
| Lynch, GS | 1 |
| Koopman, R | 1 |
| Couce, ML | 1 |
| Aldamiz-Echevarría, L | 1 |
| Bueno, MA | 1 |
| Barros, P | 1 |
| Belanger-Quintana, A | 1 |
| Blasco, J | 1 |
| García-Silva, MT | 1 |
| Márquez-Armenteros, AM | 1 |
| Vitoria, I | 1 |
| Vives, I | 1 |
| Navarrete, R | 1 |
| Fernández-Marmiesse, A | 1 |
| Pérez, B | 1 |
| Pérez-Cerdá, C | 1 |
| Mikumo, H | 1 |
| Yanagihara, T | 1 |
| Hamada, N | 1 |
| Harada, E | 1 |
| Ogata-Suetsugu, S | 1 |
| Ikeda-Harada, C | 1 |
| Arimura-Omori, M | 1 |
| Suzuki, K | 1 |
| Yokoyama, T | 1 |
| Nakanishi, Y | 1 |
| Shingu, Y | 1 |
| Shiiya, N | 1 |
| Matsuzaki, K | 1 |
| Kunihara, T | 1 |
| Murashita, T | 1 |
| Matsui, Y | 1 |
| Imokawa, S | 2 |
| Mori, K | 1 |
| Harada, M | 1 |
| Sagisaka, S | 1 |
| Sano, T | 2 |
| Uchiyama, H | 2 |
| Yasuda, K | 2 |
| Ukita, T | 1 |
| Fujisawa, T | 1 |
| Suda, T | 2 |
| Chida, K | 2 |
| Nishibe, T | 1 |
| Kondo, Y | 1 |
| Muto, A | 1 |
| Dardik, A | 1 |
| Ohara, Y | 1 |
| Kainuma, M | 1 |
| Takeda, K | 1 |
| Shigemi, K | 1 |
| Tsuneyoshi, Y | 1 |
| Hamasu, K | 1 |
| Han, L | 1 |
| Hayamizu, K | 1 |
| Denbow, DM | 1 |
| Furuse, M | 1 |
| Potrebić, O | 1 |
| Jović-Stosić, J | 1 |
| Vucinić, S | 1 |
| Tadić, J | 1 |
| Radulac, M | 1 |
| Frizzo, JK | 1 |
| Cardoso, MP | 1 |
| de Assis, AM | 1 |
| Perry, ML | 1 |
| Volonté, C | 1 |
| Frizzo, ME | 1 |
| Li, XL | 1 |
| An, Y | 1 |
| Jin, QH | 1 |
| Jin, YZ | 1 |
| MacLeod, BA | 1 |
| Wang, JT | 1 |
| Chung, CC | 1 |
| Ries, CR | 1 |
| Schwarz, SK | 1 |
| Puil, E | 1 |
| Niino, T | 1 |
| Hata, M | 1 |
| Sezai, A | 1 |
| Yoshitake, I | 1 |
| Unosawa, S | 1 |
| Fujita, K | 1 |
| Shimura, K | 1 |
| Osaka, S | 1 |
| Minami, K | 1 |
| Chiu, D | 1 |
| Peterson, L | 1 |
| Elkind, MSV | 1 |
| Rosand, J | 1 |
| Gerber, LM | 1 |
| Silverstein, MD | 1 |
| Ikegame, Y | 1 |
| Yamashita, K | 1 |
| Hayashi, S | 1 |
| Yoshimura, S | 1 |
| Nakashima, S | 1 |
| Iwama, T | 1 |
| Malhotra, RC | 1 |
| Ghia, DK | 1 |
| Cordato, DJ | 1 |
| Beran, RG | 1 |
| Moon, JM | 1 |
| Chun, BJ | 1 |
| Mise, M | 1 |
| Miyazato, M | 1 |
| Sugaya, K | 1 |
| Nishijima, S | 1 |
| Ashitomi, K | 1 |
| Hatano, T | 1 |
| Ogawa, Y | 1 |
| Achong, DM | 2 |
| Tenorio, LE | 1 |
| Ameziane, N | 1 |
| Beillat, T | 1 |
| Verpillat, P | 1 |
| Chollet-Martin, S | 1 |
| Aumont, MC | 1 |
| Seknadji, P | 1 |
| Lamotte, M | 1 |
| Lebret, D | 1 |
| Ollivier, V | 1 |
| de Prost, D | 1 |
| Ishiguro, M | 1 |
| Mikasa, S | 1 |
| Otani, M | 1 |
| Rundek, T | 1 |
| Nielsen, K | 1 |
| Phillips, S | 1 |
| Johnston, KC | 1 |
| Hux, M | 1 |
| Watson, D | 1 |
| Bhatia, M | 3 |
| Wong, FL | 1 |
| Fu, D | 1 |
| Lau, HY | 1 |
| Moochhala, SM | 2 |
| Moore, PK | 2 |
| Hagio, T | 1 |
| Matsumoto, S | 1 |
| Nakao, S | 1 |
| Matsuoka, S | 1 |
| Kawabata, K | 2 |
| Todate, A | 1 |
| Nagayama, M | 1 |
| Enomoto, N | 2 |
| Ryugo, M | 1 |
| Sawa, Y | 1 |
| Takano, H | 1 |
| Matsumiya, G | 1 |
| Iwai, S | 1 |
| Ono, M | 1 |
| Hata, H | 1 |
| Yamauchi, T | 1 |
| Nishimura, M | 1 |
| Fujino, Y | 1 |
| Matsuda, H | 1 |
| Iba, T | 1 |
| Kidokoro, A | 1 |
| Fukunaga, M | 1 |
| Takuhiro, K | 1 |
| Yoshikawa, S | 1 |
| Sugimotoa, K | 1 |
| Anderson, S | 1 |
| Shah, NP | 1 |
| Zajick, D | 1 |
| Cross, M | 1 |
| Oates, ME | 1 |
| Wu, JY | 1 |
| Chang, SS | 1 |
| Tseng, CP | 1 |
| Deng, JF | 1 |
| Lee, CC | 1 |
| Gyurkocza, B | 1 |
| Plescia, J | 1 |
| Raskett, CM | 1 |
| Garlick, DS | 1 |
| Lowry, PA | 1 |
| Carter, BZ | 1 |
| Andreeff, M | 1 |
| Meli, M | 1 |
| Colombo, G | 1 |
| Altieri, DC | 1 |
| Furusawa, T | 1 |
| Tsukioka, K | 1 |
| Fukui, D | 1 |
| Sakaguchi, M | 1 |
| Seto, T | 1 |
| Terasaki, T | 1 |
| Wada, Y | 1 |
| Amano, J | 1 |
| Gundersen, Y | 1 |
| Vaagenes, P | 1 |
| Os, Ø | 1 |
| Pillgram-Larsen, J | 1 |
| Sundnes, KO | 1 |
| Opstad, PK | 1 |
| Nakamura, N | 1 |
| Morisaki, H | 1 |
| Suzuki, T | 1 |
| Yajima, S | 1 |
| Katori, N | 1 |
| Kotake, Y | 1 |
| Funakoshi, Y | 1 |
| Yamada, S | 1 |
| Ishizaka, A | 2 |
| Takeda, J | 1 |
| Nakamura, M | 1 |
| Ogura, T | 1 |
| Miyazawa, N | 1 |
| Tagawa, A | 1 |
| Kozawa, S | 1 |
| Watanuki, Y | 1 |
| Takahashi, H | 1 |
| Endo, S | 1 |
| Sato, N | 1 |
| Yaegashi, Y | 1 |
| Suzuki, Y | 1 |
| Kojika, M | 1 |
| Yamada, Y | 1 |
| Yoshida, Y | 1 |
| Nakadate, T | 1 |
| Aoki, H | 1 |
| Inoue, Y | 1 |
| Hsiao, CT | 1 |
| Lin, LJ | 1 |
| Hsiao, KY | 1 |
| Chou, MH | 1 |
| Hsiao, SH | 1 |
| Sidhapuriwala, JN | 1 |
| Ng, SW | 1 |
| Tamizhselvi, R | 2 |
| Tanabe, M | 1 |
| Takasu, K | 1 |
| Yamaguchi, S | 1 |
| Kodama, D | 1 |
| Ono, H | 1 |
| Bruinvels, J | 1 |
| Pepplinkhuizen, L | 1 |
| Zoch-Zwierz, W | 2 |
| Rudobielska, M | 1 |
| Levy, M | 1 |
| Finestone, H | 1 |
| Fechner, C | 1 |
| Bonkowsky, HL | 2 |
| Schady, W | 1 |
| Zeman, RK | 1 |
| Burrell, MI | 1 |
| Cahow, CE | 1 |
| Caride, V | 1 |
| Skvortsova, VI | 3 |
| Gusev, EI | 3 |
| Komissarova, IA | 2 |
| Kovalenko, AV | 3 |
| Bolotov, DA | 1 |
| Fidler, SM | 1 |
| Fedorov, VN | 1 |
| Haider, R | 1 |
| Azad Khan, AK | 1 |
| Roy, SK | 1 |
| Dewan, N | 1 |
| Alam, AN | 1 |
| Mahalanabis, D | 1 |
| Fink-Bennett, D | 2 |
| Balon, HR | 1 |
| Donati, G | 1 |
| Spinazzè, R | 1 |
| Sakamaki, F | 1 |
| Urano, T | 1 |
| Sayama, K | 1 |
| Nakamura, H | 1 |
| Terashima, T | 1 |
| Waki, Y | 1 |
| Tasaka, S | 1 |
| Hasegawa, N | 1 |
| Sato, K | 1 |
| Nakagawa, N | 1 |
| Obata, T | 1 |
| Kanazawa, M | 1 |
| Furuya, KN | 1 |
| Durie, PR | 1 |
| Roberts, EA | 1 |
| Soldin, SJ | 1 |
| Verjee, Z | 1 |
| Yung-Jato, L | 1 |
| Giesbrecht, E | 1 |
| Ellis, L | 1 |
| Alicicco, E | 1 |
| Delfino, M | 1 |
| Kleszczynski, D | 1 |
| Oates, E | 1 |
| Selland, DL | 1 |
| Chin, CT | 1 |
| Shih, WJ | 2 |
| Lee, JK | 1 |
| Magoun, S | 1 |
| Wierzbinski, B | 1 |
| Ryo, UY | 1 |
| Lamont, AE | 1 |
| Joyce, JM | 1 |
| Grossman, SJ | 1 |
| Chen, CC | 1 |
| Holder, LE | 1 |
| Maunoury, C | 1 |
| Drachenberg, CI | 1 |
| Kitamura, S | 1 |
| Stryker, J | 1 |
| Siegel, A | 1 |
| Otoya, RE | 1 |
| Seltzer, AM | 1 |
| Donoso, AO | 1 |
| Antman, EM | 1 |
| Dambinova, SA | 1 |
| Raevskiĭ, KS | 2 |
| Alekseev, AA | 2 |
| Bashkatova, VG | 1 |
| Kudrin, VS | 2 |
| Iakovleva, EV | 1 |
| Malikova, LA | 1 |
| Sokolov, MA | 1 |
| Ogura, Y | 1 |
| Krams, SM | 1 |
| Martinez, OM | 1 |
| Kopiwoda, S | 1 |
| Higgins, JP | 1 |
| Esquivel, CO | 1 |
| Strauss, HW | 1 |
| Tait, JF | 1 |
| Blankenberg, FG | 1 |
| Wheeler, MD | 1 |
| Rose, ML | 1 |
| Yamashima, S | 1 |
| Seabra, V | 1 |
| Madren, J | 1 |
| Thurman, RG | 1 |
| Serena, J | 1 |
| Leira, R | 1 |
| Castillo, J | 1 |
| Pumar, JM | 1 |
| Castellanos, M | 1 |
| Dávalos, A | 1 |
| Lankes, W | 1 |
| Fleischer, K | 1 |
| Gulba, DC | 1 |
| Biasi, G | 1 |
| Marcolongo, R | 1 |
| Wienke, J | 1 |
| Falen, S | 1 |
| McCartney, W | 1 |
| Kalimi, R | 1 |
| Gecelter, GR | 1 |
| Caplin, D | 1 |
| Brickman, M | 1 |
| Tronco, GT | 1 |
| Love, C | 1 |
| Yao, J | 1 |
| Simms, HH | 1 |
| Marini, CP | 1 |
| Baumgartner, ER | 1 |
| Bachmann, C | 2 |
| Brechbühler, T | 2 |
| Wick, H | 2 |
| Chalabi, G | 1 |
| Hino, M | 1 |
| Nagatsu, T | 1 |
| Kakumu, S | 1 |
| Okuyama, S | 1 |
| Yoshii, Y | 1 |
| Nagatsu, I | 1 |
| Marsano, L | 1 |
| Mochizuki, T | 1 |
| Charron, M | 1 |
| Shah, AN | 1 |
| Dobkin, J | 1 |
| Tauxe, WN | 1 |
| Bosman, DK | 1 |
| Deutz, NE | 1 |
| Maas, MA | 1 |
| van Eijk, HM | 1 |
| Smit, JJ | 1 |
| de Haan, JG | 1 |
| Chamuleau, RA | 1 |
| Lee, YH | 1 |
| Lee, WC | 1 |
| Chen, MT | 1 |
| Huang, JK | 1 |
| Chung, C | 1 |
| Chang, LS | 1 |
| Kistler, AM | 1 |
| Ziessman, HA | 1 |
| Gooch, D | 1 |
| Bitterman, P | 1 |
| Shanley, DJ | 1 |
| Buckner, AB | 1 |
| Alexander, HG | 1 |
| Balon, H | 1 |
| Robbins, T | 1 |
| Tsai, D | 1 |
| Bhan, MK | 1 |
| Sazawal, S | 1 |
| Bhatnagar, S | 1 |
| Bhandari, N | 1 |
| Guha, DK | 1 |
| Aggarwal, SK | 1 |
| Hirata, M | 1 |
| Nalin, DR | 1 |
| Park, K | 1 |
| Umaji, K | 1 |
| Okumiya, T | 1 |
| Nishida, M | 1 |
| Sasaki, M | 1 |
| Elsas, LJ | 1 |
| Naglak, M | 1 |
| Cook, GC | 1 |
| Sapico, V | 1 |
| Shear, L | 1 |
| Litwack, G | 1 |
| Chaput, JC | 1 |
| Sol, C | 1 |
| Garcia, B | 1 |
| Perles, C | 1 |
| Petite, JP | 1 |
| Grivaux, M | 1 |
| Housset, E | 1 |
| Buxton, BH | 1 |
| Stewart, DA | 1 |
| Murray-Lyon, IM | 1 |
| Curzon, G | 1 |
| Williams, R | 1 |
| Mihatsch, MJ | 1 |
| Baumgartner, RE | 1 |
| Bühler, UK | 1 |
| Olafsson, A | 1 |
| Ohnacker, H | 1 |
| Kreimer-Birnbaum, M | 1 |
| Mosovich, LL | 1 |
| Bannerman, RM | 1 |
| Woody, NC | 1 |
| Snyder, CH | 1 |
| Harris, JA | 1 |
| Felig, P | 1 |
| Brown, WV | 1 |
| Levine, RA | 1 |
| Klatskin, G | 1 |
| Sharma, D | 1 |
| Bhardwaj, SL | 1 |
| Zefirov, YN | 1 |
| Tarassov, OF | 1 |
| Ghosh, S | 1 |
| Cüppers, H | 1 |
| Bloomer, JR | 1 |
| Berk, PD | 1 |
| Stein, JA | 1 |
| Berlin, NI | 1 |
| Tschudy, DP | 1 |
| Björnesjö, KB | 2 |
| Jarnulf, B | 1 |
| Lausing, E | 1 |
| Shanbrom, E | 1 |
| Thelin, GM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Perioperative Application of Sivelestat Sodium in Acute Type A Aortic Dissection Patients With Preoperative Moderate to Severe Hypoxemia to Shorten the Duration of Postoperative Invasive Mechanical Ventilation[NCT05874700] | 30 participants (Anticipated) | Interventional | 2023-05-31 | Not yet recruiting | |||
| Controlled and Randomized Clinical Trial for Evaluating the Effect of a Supplement of Glycine as Adjuvant in the Treatment of COVID-19 Pneumonia in Patients Initiating Mechanical Ventilation[NCT04443673] | 59 participants (Actual) | Interventional | 2020-06-15 | Terminated (stopped due to An interim analysis showed no difference in major outcomes (n=35 glycine and n=24 control participants)) | |||
| Evaluation of the Capability of a Glycine Oral Supplement for Diminishing Bronchial Inflammation in Children With Cystic Fibrosis[NCT01417481] | Phase 2 | 13 participants (Actual) | Interventional | 2012-03-31 | Terminated (stopped due to Some of the researchers finished their participation in the study.) | ||
| Comparison of Two Antalgic Strategies: Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in Emergency Departement. A Randomized Trial of Efficacy and Safety[NCT02152410] | Early Phase 1 | 100 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentages were log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
| Intervention | log (percent change) (Mean) |
|---|---|
| Glycine | -0.3908 |
| Placebo | 0.2035 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentage change was log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
| Intervention | log (percent change) (Mean) |
|---|---|
| Glycine | -0.0819 |
| Placebo | 0.1668 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentage change was log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
| Intervention | log (percent change) (Mean) |
|---|---|
| Glycine | -0.00007 |
| Placebo | 0.1739 |
"To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]).~Each respiratory symptom (Cough severity, Sputum features, Appetite, Dyspnea, and Energy perception) was evaluated in a 5-options Likert scale, ranging from 1 (better) to 5 (worse). The total score was computed by the simple sum of the five symptoms." (NCT01417481)
Timeframe: 8 weeks
| Intervention | Percentage of baseline (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Cough questionnaire score | Appetite questionnaire score | Energy questionnaire score | Body weight | Height | Heart rate | Respiratory rate | Temperature | |
| Glycine | 81.1 | 89.1 | 84.6 | 101.6 | 100.5 | 103.5 | 94.8 | 100.0 |
| Placebo | 89.1 | 132.1 | 111.5 | 103.6 | 100.5 | 98.1 | 109.0 | 100.1 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). (NCT01417481)
Timeframe: 8 weeks
| Intervention | Percentage of baseline (Mean) | ||
|---|---|---|---|
| Forced expiratory volume at first second (FEV1) | Forced expiratory flow at 25%FVC (FEF25) | Maximal forced expiratory flow (FEFmax, PEFR) | |
| Glycine | 109.7 | 133.9 | 115.3 |
| Placebo | 91.4 | 83.3 | 91.2 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). (NCT01417481)
Timeframe: 8 weeks
| Intervention | Percentage of baseline (Mean) | |
|---|---|---|
| Forced vital capacity (FVC) | Forced expiratory flow at 75%FVC (FEF75) | |
| Glycine | 104.1 | 111.8 |
| Placebo | 100.6 | 108.9 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). (NCT01417481)
Timeframe: 8 weeks
| Intervention | Percentage of baseline (Mean) | ||
|---|---|---|---|
| Peripheral oxygen saturation (SpO2) | FEV1/FVC | Forced expiratory flow at 50%FVC (FEF50) | |
| Glycine | 105.2 | 105.2 | 115.5 |
| Placebo | 98.9 | 94.9 | 93.1 |
"To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]).~In the symptoms questionnaire, each respiratory symptom (Cough severity, Sputum features, Appetite, Dyspnea, and Energy perception) was evaluated in a 5-options Likert scale, ranging from 1 (better) to 5 (worse). The total score was computed by the simple sum of the five symptoms." (NCT01417481)
Timeframe: 8 weeks
| Intervention | Percentage of baseline (Mean) | ||
|---|---|---|---|
| Sputum questionnaire score | Dyspnea questionnaire score | Total questionnaire score | |
| Glycine | 82.0 | 75.6 | 77.7 |
| Placebo | 102.6 | 103.8 | 98.7 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentages were log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
| Intervention | log (percent change) (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Myeloperoxidase | IL-1 | IL-4 | IL-6 | IL-7 | IL-8 | IL-12 | IL-13 | G-CSF | IFN-gamma | MCP-1 | MIP-1beta | |
| Glycine | -0.4361 | -0.1635 | 0.2964 | 0.0085 | 0.0356 | -0.1466 | 0.3203 | -0.0561 | -0.0776 | 0.3272 | -0.0836 | 0.0330 |
| Placebo | -0.2906 | -0.0352 | 0.1470 | 0.2255 | 0.0819 | -0.2364 | 0.2603 | 0.1953 | 0.2272 | 0.3639 | 0.0472 | -0.0608 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentage change was log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
| Intervention | log (percent change) (Mean) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Myeloperoxidase | IL-1 | IL-2 | IL-4 | IL-5 | IL-7 | IL-8 | IL-10 | IL-12 | IL-13 | IL-17 | IFN-gamma | MCP-1 | MIP-1beta | TNF-alpha | GM-CSF | |
| Glycine | 0.1294 | -0.0918 | 0.0233 | -0.0161 | 0.2498 | 0.0611 | -0.0824 | 0.0549 | 0.1675 | 0.1630 | 0.0680 | 0.0248 | 0.0042 | -0.0303 | 0.0412 | -0.0538 |
| Placebo | 0.0669 | -0.0102 | -0.0274 | 0.0522 | 0.1304 | 0.1387 | 0.0542 | 0.0074 | 0.0677 | 0.0953 | 0.1140 | 0.0649 | 0.2608 | 0.0977 | 0.1568 | -0.0822 |
4 reviews available for glycine and Acute Disease
| Article | Year |
|---|---|
Neurologic manifestations of acute porphyria.
Topics: Acute Disease; Aminolevulinic Acid; Animals; Central Nervous System; Depression; Electrophysiology; | 1982 |
The role of morphine-augmented cholescintigraphy in the detection of acute cholecystitis.
Topics: Acute Disease; Aniline Compounds; Cholecystitis; Glycine; Humans; Imino Acids; Morphine; Organotechn | 1993 |
[Pathophysiology of acute lung injury].
Topics: Acute Disease; Animals; Biomarkers; Capillary Permeability; Cell Adhesion Molecules; Clinical Trials | 1996 |
[Direct thrombin antagonists].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithromb | 2001 |
16 trials available for glycine and Acute Disease
| Article | Year |
|---|---|
[Effect of sivelestat sodium on acute lung injury after acute aortic dissection].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aortic Aneurysm; Aortic Dissection; Female; Glycine; | 2008 |
Comparison of outcomes after intracerebral hemorrhage and ischemic stroke.
Topics: Acute Disease; Aged; Brain Ischemia; Cerebral Hemorrhage; Cohort Studies; Disability Evaluation; Dou | 2010 |
Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial.
Topics: Acute Disease; Aftercare; Aged; Canada; Female; Glycine; Glycine Agents; Health Resources; Humans; I | 2004 |
Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study.
Topics: Acute Disease; Aged; Cardiopulmonary Bypass; Female; Glycine; Humans; Interleukin-8; Leukocyte Elast | 2006 |
Capacity of glycine to modulate early inflammatory disturbances after serious gunshot injuries in the pig.
Topics: Acute Disease; Animals; Blood Pressure; Cytokines; Glutathione; Glycine; Glycine Agents; Heart Rate; | 2007 |
Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction.
Topics: Acute Disease; Adolescent; Adult; Aged; Glycine; Humans; Interleukin-8; Leukocyte Elastase; Leukocyt | 2006 |
[A comprehensive clinico-neurophysiological study of the efficacy of the pharmaceutical preparation glycine in acute ischemic stroke].
Topics: Acute Disease; Aged; Brain; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; F | 1995 |
Management of acute diarrhoea in diabetic patients using oral rehydration solutions containing glucose, rice, or glycine.
Topics: Acute Disease; Adolescent; Adult; Blood Glucose; Defecation; Diabetes Complications; Diarrhea; Femal | 1994 |
[A clinical study to determine the optimal dosage of ST-679 in the treatment of rheumatic diseases].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Dist | 1993 |
[Clinical trial comparing a new NSAID with 2 different dosages and diclofenac in patients with arthralgia in acute phase].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Drug Administration Sched | 1995 |
[Neuroprotective effects of glycine in the acute period of ischemic stroke].
Topics: Acute Disease; Administration, Sublingual; Adult; Aged; Autoantibodies; Brain Ischemia; Double-Blind | 1999 |
Neurological deterioration in acute lacunar infarctions: the role of excitatory and inhibitory neurotransmitters.
Topics: Acute Disease; Aged; Brain Infarction; Disease Progression; Female; gamma-Aminobutyric Acid; Glutami | 2001 |
[Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Female; Foll | 2001 |
Acupuncture in the treatment of renal colic.
Topics: Acupuncture Therapy; Acute Disease; Adult; Analgesics; Colic; Dipyrone; Drug Combinations; Female; G | 1992 |
Comparison of glucose/electrolyte and maltodextrin/glycine/glycyl-glycine/electrolyte oral rehydration solutions in acute diarrhea in children.
Topics: Acute Disease; Breast Feeding; Child, Preschool; Citrates; Defecation; Diarrhea; Diarrhea, Infantile | 1991 |
Glycine, glycyl-glycine and maltodextrin based oral rehydration solution. Assessment of efficacy and safety in comparison to standard ORS.
Topics: Acute Disease; Child, Preschool; Dehydration; Double-Blind Method; Fluid Therapy; Gastroenteritis; G | 1990 |
89 other studies available for glycine and Acute Disease
| Article | Year |
|---|---|
REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice.
Topics: Acute Disease; Animals; Antibodies; Apoptosis; Chemical and Drug Induced Liver Injury; Circadian Rhy | 2021 |
Acute leukemias in 2020: state of the art.
Topics: Acute Disease; Aminopyridines; Antineoplastic Agents; Antineoplastic Agents, Immunological; Congress | 2020 |
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.
Topics: Acute Disease; Aminopyridines; Animals; Cell Line, Tumor; Doxycycline; Drug Resistance, Neoplasm; En | 2021 |
Methylenecyclopropyl glycine, not pesticide exposure as the primary etiological factor underlying hypoglycemic encephalopathy in Muzaffarpur, India.
Topics: Acute Disease; Acute Febrile Encephalopathy; Animals; Cyclopropanes; DDT; Disease Models, Animal; Fr | 2019 |
A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency.
Topics: Acetyl-CoA C-Acetyltransferase; Acidosis; Acute Disease; Amino Acid Metabolism, Inborn Errors; Gluta | 2013 |
Combined effects of sivelestat and resveratrol on severe acute pancreatitis-associated lung injury in rats.
Topics: Acute Disease; Amylases; Animals; Arterial Pressure; Bronchoalveolar Lavage Fluid; Glycine; Interleu | 2014 |
D-serine prevents cognitive deficits induced by acute stress.
Topics: Acute Disease; Animals; Cognition Disorders; Corticosterone; Disease Models, Animal; Glycine; Hippoc | 2014 |
Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.
Topics: Acute Disease; Amino Acids; Animals; Anticonvulsants; Aspartic Acid; Bridged Bicyclo Compounds, Hete | 2014 |
Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Topics: Acute Disease; Animals; B-Lymphocytes; Biomarkers; Boron Compounds; Calcineurin Inhibitors; Cyclospo | 2015 |
Acute eosinophilic pneumonia associated with glyphosate-surfactant exposure.
Topics: Acute Disease; Adult; Bronchoalveolar Lavage Fluid; Environmental Exposure; Female; Glycine; Glyphos | 2015 |
Glycine restores the anabolic response to leucine in a mouse model of acute inflammation.
Topics: Acute Disease; Anabolic Agents; Animals; Dose-Response Relationship, Drug; Drug Resistance; Drug Syn | 2016 |
Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia.
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Asymptomatic Diseases; Carnitine; Child; Child, | 2017 |
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in mice.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Female; Gefitinib; Glycine; Humans; Kaplan-Mei | 2017 |
[Acute respiratory failure due to pneumocystis pneumonia successfully treated with combined use of sivelestat sodium hydrate].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Drug Therapy, Combination; Ganciclovir; Gl | 2008 |
Protective effect of sivelestat sodium (Eraspol) on postoperative lung dysfunction in patients with type A acute aortic dissection: a pilot study.
Topics: Acute Disease; Analysis of Variance; Aortic Aneurysm, Thoracic; Aortic Dissection; Cardiopulmonary B | 2008 |
l-Serine induces sedative and hypnotic effects acting at GABA(A) receptors in neonatal chicks.
Topics: Acute Disease; Animals; Animals, Newborn; Chickens; Disease Models, Animal; Glycine; Hypnotics and S | 2008 |
[Acute glyphosate-surfactant poisoning with neurological sequels and fatal outcome].
Topics: Acute Disease; Akinetic Mutism; Fatal Outcome; Female; Glycine; Glyphosate; Herbicides; Humans; Midd | 2009 |
Effects of acute perinatal asphyxia in the rat hippocampus.
Topics: Acute Disease; Animals; Animals, Newborn; Asphyxia; Biological Transport; Cell Survival; Female; Glu | 2010 |
[Changes of gamma-aminobutyric acid and glycine released in the medial vestibular nucleus following acute hypotension in conscious rats].
Topics: Acute Disease; Animals; Chromatography, High Pressure Liquid; Ear, Inner; gamma-Aminobutyric Acid; G | 2010 |
Analgesic properties of the novel amino acid, isovaline.
Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; beta-Alanine; Chronic Disease; Cisterna Magna; Fem | 2010 |
Efficacy of neutrophil elastase inhibitor on type A acute aortic dissection.
Topics: Acute Disease; Aged; Antithrombin III; Aortic Aneurysm; Aortic Dissection; Blood Vessel Prosthesis I | 2010 |
Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema.
Topics: Acute Disease; Angiopoietin-1; Animals; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Ce | 2010 |
Glyphosate-surfactant herbicide-induced reversible encephalopathy.
Topics: Acidosis; Acute Disease; Aged; Coma; Glasgow Coma Scale; Glycine; Glyphosate; Herbicides; Humans; Ma | 2010 |
Predicting acute complicated glyphosate intoxication in the emergency department.
Topics: Acute Disease; Adult; Age Factors; Aged; Alanine Transaminase; Emergency Service, Hospital; Female; | 2010 |
[Epidemiological study of glyphosate herbicide poisoning].
Topics: Accidents; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Femal | 2011 |
Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats.
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Female; Glutamic Acid; Glycine; Gly | 2003 |
Early morphine administration to expedite gallbladder visualization during cholescintigraphy for acute cholecystitis.
Topics: Acute Disease; Aniline Compounds; Cholecystitis; Female; Gallbladder; Glycine; Humans; Imino Acids; | 2003 |
Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.
Topics: Acute Disease; Adult; Aged; Alleles; Amino Acid Substitution; Aspartic Acid; Case-Control Studies; C | 2003 |
[A case of acute poisoning caused by the inhalation of a nonselective herbicide REBIN GT SC (butafenacil and glyphosate isopropylamine)].
Topics: Acute Disease; Aged; Cysteine; Drug Combinations; Fluid Therapy; Glutathione; Glycine; Glyphosate; H | 2004 |
Role of hydrogen sulfide in acute pancreatitis and associated lung injury.
Topics: Acute Disease; Alkynes; Amylases; Animals; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; C | 2005 |
Sivelestat, a specific neutrophil elastase inhibitor, prevented phorbol myristate acetate-induced acute lung injury in conscious rabbits.
Topics: Acute Disease; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; | 2005 |
[Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy].
Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Glycine; Humans; Lung Diseases, Interstitial | 2006 |
Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters.
Topics: Acute Disease; Animals; Cricetinae; Glycine; Leukocyte Elastase; Lipopolysaccharides; Male; Microcir | 2006 |
A positional maneuver to augment conventional cholescintigraphy in the evaluation of acute acalculous cholecystitis.
Topics: Abdominal Pain; Acalculous Cholecystitis; Acute Disease; Aniline Compounds; Fever; Gallbladder; Glyc | 2006 |
Parenteral glyphosate-surfactant herbicide intoxication.
Topics: Acute Disease; Adult; Glycine; Glyphosate; Hemolysis; Herbicides; Humans; Injections, Intravenous; M | 2006 |
Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.
Topics: Acute Disease; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell | 2006 |
The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection.
Topics: Acute Disease; Aged; Aortic Aneurysm; Aortic Dissection; Cardiopulmonary Bypass; Female; Glycine; Hu | 2006 |
Inhibition of neutrophil elastase attenuates gut mucosal injury evoked by acute alveolar hypoxia in rabbits.
Topics: Acute Disease; Animals; Glycine; HMGB1 Protein; Hypoxia; Intestinal Mucosa; Leukocyte Elastase; Male | 2007 |
[Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
Topics: Acute Disease; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Chronic Disease; Disease Pro | 2007 |
Acute pancreatitis caused by severe glyphosate-surfactant oral intoxication.
Topics: Acute Disease; Aged, 80 and over; Glycine; Glyphosate; Herbicides; Humans; Male; Pancreatitis; Paren | 2008 |
Pro-inflammatory effects of hydrogen sulphide on substance P in caerulein-induced acute pancreatitis.
Topics: Acute Disease; Alkynes; Animals; Ceruletide; Cystathionine beta-Synthase; Glycine; Hydrogen Sulfide; | 2008 |
Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
Topics: Acute Disease; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glycine; | 2008 |
Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury.
Topics: Acute Disease; Alkynes; Animals; Ceruletide; Chemokine CCL5; Chemokines; Cystathionine gamma-Lyase; | 2008 |
Impaired glycine-serine conversion and increased plasma taurine levels in episodic psychotic patients with psychedelic symptoms.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Acute Disease; Adult; Female; Glycine; Ha | 1984 |
[Glycine transamidinase (ADT) activity in the serum and urine of children with lipoid nephrosis].
Topics: Acute Disease; Amidinotransferases; Child; Child, Preschool; Convalescence; Enzyme Activation; Glyci | 1983 |
Action of renal vasodilators in dogs following acute biliary obstruction.
Topics: Acetylcholine; Acute Disease; Angiotensin II; Animals; Bile; Bradykinin; Cholestasis; Diuresis; Dogs | 1984 |
[Glycine amidinotransferase activity of the blood and urine of children with acute streptococcal glomerulonephritis].
Topics: Acute Disease; Adolescent; Amidinotransferases; Child; Child, Preschool; Glomerulonephritis; Glycine | 1982 |
Diagnostic utility of cholescintigraphy and ultrasonography in acute cholecystitis.
Topics: Acute Disease; Adult; Aged; Chemical Phenomena; Chemistry; Cholecystitis; Cholelithiasis; Chronic Di | 1981 |
Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Cell Count; Chemotaxis; Escherichia coli; Glyc | 1996 |
Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function.
Topics: 4-Aminobenzoic Acid; Acute Disease; Adolescent; Aminohippuric Acids; Child; Child, Preschool; Chroni | 1995 |
Gallbladder nonvisualization with pericholecystic rim sign: morphine-augmentation optimizes diagnosis of acute cholecystitis.
Topics: Acute Disease; Aniline Compounds; Case-Control Studies; Cholecystitis; Chronic Disease; False Positi | 1996 |
Morphine-augmented cholescintigraphy enhances duodenogastric reflux.
Topics: Acute Disease; Aniline Compounds; Cholecystitis; Chronic Disease; Duodenogastric Reflux; Evaluation | 1995 |
Acute cholecystitis detected on a Tc-99m sestamibi myocardial imaging.
Topics: Acute Disease; Adult; Aniline Compounds; Cholecystitis; Gallbladder; Glycine; Heart; Humans; Imino A | 1996 |
Morphine augmentation increases gallbladder visualization in patients pretreated with cholecystokinin.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aniline Compounds; Cholecystitis; Cholecy | 1997 |
Abdominal aortic aneurysm visualized with hepatobiliary scintigraphy.
Topics: Acute Disease; Aged; Aniline Compounds; Aortic Aneurysm, Abdominal; Bile Ducts, Intrahepatic; Cholec | 1997 |
Acute and long-lasting effects of neonatal hypoxia on (+)-3-[125I]MK-801 binding to NMDA brain receptors.
Topics: Acute Disease; Animals; Animals, Newborn; Brain Chemistry; Brain Damage, Chronic; Dizocilpine Maleat | 1997 |
Another chapter of the antithrombin story has been written...
Topics: Acute Disease; Antithrombins; Coronary Disease; Glycine; Heparin; Hirudin Therapy; Humans; Piperidin | 1997 |
[Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic stroke].
Topics: Acute Disease; Aspartic Acid; Brain Ischemia; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycin | 1999 |
Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation.
Topics: Acute Disease; Aniline Compounds; Animals; Annexin A5; Glycine; Graft Rejection; Imino Acids; Liver; | 2000 |
Dietary glycine blunts lung inflammatory cell influx following acute endotoxin.
Topics: Acute Disease; Animals; Calcium; Cells, Cultured; Dietary Supplements; Drug Administration Schedule; | 2000 |
Dietary glycine blunts lung inflammatory cell influx following acute endotoxin.
Topics: Acute Disease; Animals; Calcium; Cells, Cultured; Dietary Supplements; Drug Administration Schedule; | 2000 |
Dietary glycine blunts lung inflammatory cell influx following acute endotoxin.
Topics: Acute Disease; Animals; Calcium; Cells, Cultured; Dietary Supplements; Drug Administration Schedule; | 2000 |
Dietary glycine blunts lung inflammatory cell influx following acute endotoxin.
Topics: Acute Disease; Animals; Calcium; Cells, Cultured; Dietary Supplements; Drug Administration Schedule; | 2000 |
Hepatobiliary scan showing type II choledochal cyst.
Topics: Acute Disease; Aniline Compounds; Cholecystitis; Choledochal Cyst; Female; Glycine; Humans; Imino Ac | 2001 |
Diagnosis of acute cholecystitis: sensitivity of sonography, cholescintigraphy, and combined sonography-cholescintigraphy.
Topics: Acute Disease; Adult; Aged; Aniline Compounds; Cholecystectomy, Laparoscopic; Cholecystitis; Choleli | 2001 |
Acute neonatal nonketotic hyperglycinemia: normal propionate and methylmalonate metabolism.
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Coenzyme A; Female; Fi | 1975 |
[Stosstherapy with steroid-containing combination preparation "Ambene" in the acute stages of rheumatic diseases].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aluminum; Aminopyrine; Anti-Inflammato | 1975 |
Glycylprolyl beta-naphthylamidase activity in human serum.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferas | 1975 |
Cholescintigraphic demonstration of transient and functional common bile duct obstruction in a patient with acute pancreatitis.
Topics: Acute Disease; Aged; Aniline Compounds; Cholestasis, Extrahepatic; Common Bile Duct Diseases; Diagno | 1992 |
Hepatobiliary imaging in acute alcoholic hepatitis with fatty liver.
Topics: Acute Disease; Adult; Aniline Compounds; Fatty Liver; Female; Glycine; Hepatitis, Alcoholic; Humans; | 1992 |
Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral cortex microdialysis.
Topics: Acute Disease; Amino Acids; Animals; Aspartic Acid; Cerebral Cortex; Dialysis; gamma-Aminobutyric Ac | 1992 |
Morphine-augmented cholescintigraphy in acute cholecystitis. A satisfactory alternative to delayed imaging.
Topics: Acute Disease; Aniline Compounds; Cholecystitis; Fasting; Female; Gallbladder; Glycine; Humans; Imin | 1991 |
The scintigraphic "duodenal cut off sign" in acute pancreatitis.
Topics: Acute Disease; Adult; Aniline Compounds; Duodenum; Female; Glycine; Humans; Imino Acids; Organotechn | 1991 |
Morphine-augmented cholescintigraphy: its efficacy in detecting acute cholecystitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aniline Compounds; Cholecystitis; Female; Glycine; Hu | 1991 |
[Study of impaired metabolism of guanidinoacetic acid in uremia--the compensatory role of the pancreas in guanidinoacetic acid synthesis].
Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Ethionine; Glycine; Insulin; Male; Pancreas | 1989 |
Comparison of oral rehydration solutions.
Topics: Acute Disease; Diarrhea; Fluid Therapy; Food, Formulated; Glycine; Humans; Malabsorption Syndromes | 1989 |
[Guanidino compounds in liver diseases--clinical evaluation of guanidino acetic acid in acute hepatic failure].
Topics: Acute Disease; Adolescent; Adult; Aged; Biomarkers; Child; Child, Preschool; Female; Glycine; Hepati | 1989 |
Acute and chronic-intermittent isovaleric acidemia: diagnosis and glycine therapy.
Topics: Acute Disease; Child; Child, Preschool; Chronic Disease; Female; Glycine; Hemiterpenes; Humans; Isov | 1988 |
Increased glycine absorption rate associated with acute bacterial infections in man.
Topics: Acute Disease; Adult; Chronic Disease; gamma-Globulins; Glycine; Hemoglobinometry; Humans; Intestina | 1973 |
Translocation of inducible tyrosine aminotransferase to the mitochondrial fraction. Facilitation by acute uremia and other conditions.
Topics: Acute Disease; Animals; Antigen-Antibody Reactions; Aspartate Aminotransferases; Biological Transpor | 1974 |
[Acute intermittent porphyria associated with Biermer's anemia. Value of the glycocoll test].
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Adult; Anemia, Pernicious; Feces; Female; Genes, Domina | 1972 |
Plasma amino acids in experimental acute hepatic failure and their relationship to brain tryptophan.
Topics: Acute Disease; Alanine; Amino Acids; Animals; Brain Chemistry; Disease Models, Animal; Glycine; Hepa | 1974 |
[Non-ketotic hyperglycinemia: peracute course in neonatal period].
Topics: Acute Disease; Amino Acids; Biopsy; Brain; Cerebellum; Fatty Liver; Glycine; Hiccup; Humans; Infant, | 1971 |
Acute intermittent porphyria. A clinical, biochemical and family study.
Topics: Acetone; Acute Disease; Adenosine Monophosphate; Child, Preschool; Glycine; Humans; Injections, Intr | 1971 |
Hyperprolinemia: clinical and biochemical family study.
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Brain; Bronchopneumonia; Central Nervous System | 1969 |
Glucose homeostasis in viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Alanine; Amino Acids; Biopsy; Blood Glucose; Dietary Carbohydrates | 1970 |
Acute intermittent porphyria.
Topics: Acute Disease; Child; Coenzyme A; Female; Glycine; Humans; Male; Pedigree; Porphyrias; Porphyrins | 1970 |
[Ciloprin cum anesthetico. Clinical and ambulatory therapy in inflammatory ear diseases].
Topics: Acute Disease; Ear Diseases; Glycine; Humans; Otitis Externa; Otitis Media; Sulfonamides | 1970 |
Blood volume and bilirubin production in acute intermittent porphyria.
Topics: Acute Disease; Bilirubin; Blood Volume; Carbon Isotopes; Chromium Isotopes; Erythrocyte Aging; Eryth | 1971 |
The erythrocyte plasma distribution of amino acids in health and disease.
Topics: Acute Disease; Adolescent; Adult; Alanine; Amino Acids; Anemia, Hemolytic; Anemia, Pernicious; Bronc | 1968 |
Uptake of labelled amino acids into human erythrocytes in disease.
Topics: Acute Disease; Alanine; Amino Acids; Anemia; Bronchitis; Bronchopneumonia; Carbon Isotopes; Erythroc | 1968 |
Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
Topics: Acute Disease; Adult; Blood Pressure; Chemical Precipitation; Factor VIII; Fibrinogen; Glycine; Hemo | 1969 |